UNITED THERAPEUTICS CORP (UTHR)
NASDAQ • Healthcare
Last close at August 10, 2026 at 20:00 UTC
Fundamentals Charts
About UNITED THERAPEUTICS CORP
United Therapeutics Corporation is a NASDAQ-listed biotechnology company focused on discovering, developing, and bringing to market therapies for chronic and severe illnesses, especially pulmonary hypertension and certain cancers. Its portfolio spans marketed medicines and pipeline programs, and it generated $3.2 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
UNITED THERAPEUTICS CORP's Technical Indicators Summary
UTHR is marked as a sell as momentum appears mixed while medium-term trend pressure builds. The ADX sits near the mid‑20s, indicating no strong directional trend, and short‑term momentum measures are neutral to slightly weak with RSI near the midpoint and MACD marginally negative, while the fast stochastic shows overbought readings. Price sits above the 200‑day averages but is encountering resistance from several medium-term moving averages, and volatility is moderate with an ATR roughly 2.7%. On balance, volume (OBV) shows accumulation but is outweighed by medium‑term resistance. Technical takeaway: Sell — medium‑term moving averages and mixed momentum favor caution.
| Indicator | Value |
|---|---|
RSI (14) | 48.20 |
Stochastic %K (14, 3, 3) | 85.26 |
CCI (20) | 58.13 |
WPR (14) | -22.97 |
Momentum (10) | 1.72 |
MFI | 45.00 |
MACD Level (12, 26) | -3.97 |
Bollinger Bands | $515.07 - $539.79 |
ATR (14) | $14.18 (2.68%) |
ADX (14) | 24.66 |
OBV | 15,528,016 |
Classic Pivot Point | $534.82 |
Fibonacci Pivot Point | $534.82 |
Simple Moving Averages | $517.24 - $552.83(5 indicators) |
Exponential Moving Averages | $502.61 - $537.89(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
In the prior session, UTHR softened a touch, closing at 529.66 with a subtle -1.70% decline. UTHR chairperson and CEO sold $5.05 million of stock, signaling potential insider-sentiment shift.
Trading Volume
Below 10d avg (662.9K)
387.7K
vs S&P 500 Today
Underperforming Market
-1.64%
52-Week Position
Upper range
74.9%
Updated: August 11, 2026 at 13:08 UTC